Cargando…
Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models
Alzheimer’s disease (AD) is an age-dependent, progressive disorder affecting millions of people. Currently, the therapeutics for AD only treat the symptoms. Although they have been used to discover new products of interest for this disease, mammalian models used to investigate the molecular determin...
Autores principales: | Navarro-Hortal, María D., Romero-Márquez, Jose M., Osta, Safa, Jiménez-Trigo, Victoria, Muñoz-Ollero, Pedro, Varela-López, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149938/ https://www.ncbi.nlm.nih.gov/pubmed/35645249 http://dx.doi.org/10.3390/diseases10020028 |
Ejemplares similares
-
An Olive-Derived Extract 20% Rich in Hydroxytyrosol Prevents β-Amyloid Aggregation and Oxidative Stress, Two Features of Alzheimer Disease, via SKN-1/NRF2 and HSP-16.2 in Caenorhabditis elegans
por: Romero-Márquez, Jose M., et al.
Publicado: (2022) -
Novel Polymeric Nanocarriers Reduced Zinc and Doxycycline Toxicity in the Nematode Caenorhabditis elegans
por: Toledano, Manuel, et al.
Publicado: (2019) -
Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model
por: Van Assche, Roel, et al.
Publicado: (2014) -
Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer’s Disease
por: Kang, Nianxin, et al.
Publicado: (2022) -
Methoxylation enhances stilbene bioactivity in Caenorhabditis elegans
por: Wilson, Mark A, et al.
Publicado: (2008)